Pediatrix Medical Group, Inc. reported $1.95B of revenue over the trailing twelve months, +0.51% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $1.95B (to Q2 2026). Net income: $175M, trailing twelve months to Q2 2026. Free cash flow: $229M, trailing twelve months to Q2 2026. Operating margin: 11%, trailing twelve months to Q2 2026.

MDPediatrix Medical Group, Inc.

Healthcare

$26.65+64% 1Y

$26.65

$15.8052 weeks$27.07

MD as reported

Pediatrix Medical Group, Inc. reported $1.95B of revenue over the trailing twelve months, +0.51% on the year before. 10 reported series are charted on this page, each one as filed.

$1.95B

Revenue, trailing twelve months · to Q2 2026 · +0.51% against the twelve months before

Net income: $175M
Net income · +59% year on year · trailing twelve months to Q2 2026
Free cash flow: $229M
Free cash flow · +0.72% year on year · trailing twelve months to Q2 2026
Operating margin: 11%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for MD, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$1.95B	+0.51%	Q2 2026
Net income	$175M	+59%	Q2 2026
EPS	$2.09	+61%	Q2 2026
Operating margin	11%	n/a	Q2 2026
Net margin	8.9%	n/a	Q2 2026
ROE	19%	n/a	Q2 2026
ROA	7.8%	n/a	Q2 2026
ROIC	16%	n/a	Q2 2026
Free cash flow	$229M	+0.72%	Q2 2026
P/E	12.8	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.